Mirum Pharma's Phase 2b Study Of Volixibat For Sclerosing Cholangitis Meets End Point, Shares Gain NASDAQ · Markets 27m ago
Meta AI Capex (Up 7%) Is a Bad Surprise -- Could This Be the Next Metaverse? NASDAQ · Markets 36m ago
Investment Advisor Adds $2.9 Million of Fixed Income ETF, According to Latest SEC Filing NASDAQ · Markets 37m ago